ConductScience.org, home

Paper40920775

Targeting the Exon2 splice cis-element in PD-1 and its effects on lymphocyte function.

Tan Y and 6 others. PLoS One, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Targeting the Exon2 splice cis-element in PD-1 and its effects on lymphocyte function. Papers, record 40920775. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40920775

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting the Exon2 splice cis-element in PD-1 and its effects on lymphocyte function.
PubMed
Journal
PLoS One
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-10-30
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tan YYuto
2Kumagai-Takei NNaokohttps://orcid.org/0000-0001-7612-3689
3Shimizu YYurika
4Yamasaki AAkira
5Hara-Yamamoto MMari
6Mitani SShigeru
7Ito TTatsuo

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Programmed Cell Death 1 ReceptorMajor topic
ExonsMajor topic
CD8-Positive T-LymphocytesMajor topic
RNA SplicingMajor topic
Humans
CRISPR-Cas Systems
Cytokines
RNA Precursors
Lymphocyte Activation
Cell Proliferation

Source PubMed

Download CSV of topics

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138823437DC-derived CXCL10 promotes CTL activation to suppress ovarian cancer.Transl Res2024https://conductscience.org/library/papers/38823437PubMed
238043270An anti-PD-1 antisense oligonucleotide promotes the expression of soluble PD-1 by blocking the interaction between SRSF3 and an exonic splicing enhancer of PD-1 exon 3.Int Immunopharmacol2024https://conductscience.org/library/papers/38043270PubMed
328881701PD1 signal transduction pathways in T cells.Oncotarget2017https://conductscience.org/library/papers/28881701PubMed
437124148Non-viral chimeric antigen receptor (CAR) T cells going viral.Immunooncol Technol2023https://conductscience.org/library/papers/37124148PubMed
512969992Fractalkine in vascular biology: from basic research to clinical disease.Arterioscler Thromb Vasc Biol2004https://conductscience.org/library/papers/12969992PubMed
636002647Eosinophil-lymphocyte interactions in the tumor microenvironment and cancer immunotherapy.Nat Immunol2022https://conductscience.org/library/papers/36002647PubMed
731611251Biology and therapeutic potential of interleukin-10.J Exp Med2020https://conductscience.org/library/papers/31611251PubMed
837907738CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential.Exp Mol Med2023https://conductscience.org/library/papers/37907738PubMed
938401888PD-1 regulation in immune homeostasis and immunotherapy.Cancer Lett2024https://conductscience.org/library/papers/38401888PubMed
108057683Establishment and characterization of the T-cell line, EBT-8 latently infected with Epstein-Barr virus from large granular lymphocyte leukemia.Leukemia1994https://conductscience.org/library/papers/8057683PubMed
1123223433The role of B7 family molecules in hematologic malignancy.Blood2013https://conductscience.org/library/papers/23223433PubMed
1236525971IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer.Cancer Cell2023https://conductscience.org/library/papers/36525971PubMed
1310837060CD8+ T cell effector mechanisms in resistance to infection.Annu Rev Immunol2000https://conductscience.org/library/papers/10837060PubMed
1438660299Targeting PD-1/PD-L-1 immune checkpoint inhibition for cancer immunotherapy: success and challenges.Front Immunol2024https://conductscience.org/library/papers/38660299PubMed
1524240160A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application.Nat Immunol2013https://conductscience.org/library/papers/24240160PubMed
1621830940Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.N Engl J Med2011https://conductscience.org/library/papers/21830940PubMed
1715292066IL-8 responsiveness defines a subset of CD8 T cells poised to kill.Blood2004https://conductscience.org/library/papers/15292066PubMed
1832665590Structure-based design of gRNA for Cas13.Sci Rep2020https://conductscience.org/library/papers/32665590PubMed
1912445288GM-CSF-based cancer vaccines.Immunol Rev2002https://conductscience.org/library/papers/12445288PubMed
2026558876CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition.Am J Clin Oncol2016https://conductscience.org/library/papers/26558876PubMed

See all 24 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
41457218RNA modifications: roles in immune cell biology and tumor regulation.Cancer Cell Int2025https://conductscience.org/library/papers/41457218

Source PubMed

Download CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CSF21437PubTator's text mininghttps://conductscience.org/library/genes/1437NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene
TRBV20OR9-26962PubTator's text mininghttps://conductscience.org/library/genes/6962NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40920775

GET https://conductscience.org/api/papers/v1/40920775/references?page=2